3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Conditions
Pain
14
Neoplasms
6
Colonic Neoplasms
5
Agnosia
5
Lung Neoplasms
4
Head and Neck Neoplasms
4
Cancer Pain
4
Breast Neoplasms
4
Rectal Neoplasms
3
Prostatic Neoplasms
3
Pain, Postoperative
3
Urinary Bladder Neoplasms
2
Sarcoma
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
2
Pleural Effusion, Malignant
2
Pancreatic Neoplasms
2
Lymphoma, Follicular
2
Diverticulosis, Colonic
2
Chronic Pain
2
Breakthrough Pain
2
post laminectomy syndrome
1
Waldenstrom Macroglobulinemia
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thrombocythemia, Essential
1
Terminal Cancer
1
Sezary Syndrome
1
Primary Myelofibrosis
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Precancerous Conditions
1
Interventions
Pregabalin
5
Lidocaine
4
Surveys and Questionnaires
3
Bupivacaine
3
ziconotide
2
Transcranial Magnetic Stimulation
2
Oxycodone
2
Gabapentin
2
Capsaicin
2
Amitriptyline
2
onabotulinum toxin A
1
Yoga
1
Vitamin B 6
1
Vitamin B 12
1
Vinorelbine
1
Vincristine
1
Transcutaneous Electric Nerve Stimulation
1
Thalidomide
1
Telmisartan
1
Tapentadol
1
Spinal Cord Stimulation
1
Sodium Chloride
1
Saline Solution
1
Radiofrequency Ablation
1
Plastic Surgery Procedures
1
Paclitaxel
1
Oxaliplatin
1
Morphine
1
Methadone
1
Manipulation, Osteopathic
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neuralgia
×
Fentanyl
×
Clear all
NCT01946555
2016-04-14
RER
Mario Negri Institute for Pharmacological Research
Completed
150 enrolled